Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Albert David Ltd

NSE: ALBERTDAVD · BSE: 524075 · Pharmaceuticals & Biotechnology · 19 announcements

Share price
₹810.00
Market cap
₹462.3 Cr
Revenue (annual)
₹333.6 Cr
Net profit (annual)
₹-1.49 Cr
P/E (TTM)
20.5×Sector 47.4×
Promoter holding
62.24%+0.00% QoQ
FII holding
0.57%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

15:41 IST BSE
Annual General Meeting

Albert David Annual General Meeting

Albert David Limited submitted the minutes of its 87th Annual General Meeting held on August 6, 2026. The meeting successfully concluded the proposed agenda items.

20:31 IST BSE
Annual General Meeting

Albert David Annual General Meeting

Albert David Limited conducted its 87th Annual General Meeting via video conferencing. The meeting covered adoption of financial statements, dividend declaration, and various director appointments.

19:38 IST BSE
Management Change

Albert David Management Change

Dr. Kuntal Ganguly has resigned as Head of R&D at Albert David Limited, effective August 5, 2026.

15:52 IST BSE
Board Meeting Date

Albert David Board Meeting Date

Albert David Limited has scheduled a board meeting on August 6, 2026, to consider and approve its unaudited financial results for the quarter ended June 30, 2026.

17:30 IST BSE
Other Announcement

Albert David Other Announcement

Albert David Ltd has filed its quarterly shareholding pattern for the period ended June 30, 2026, in compliance with regulatory requirements.

19:17 IST BSE
Annual General Meeting

Albert David Annual General Meeting

Albert David Limited has scheduled its 87th Annual General Meeting for August 6, 2026. The company also released its Annual Report for fiscal year 2025-2026.

14:59 IST BSE
Management Change

Albert David Management Change

Albert David Ltd announced the resignation of Cluster Head Mr. Saikath Banerjee, effective July 4, 2026. His departure marks a change in senior management for the company.

20:16 IST BSE
Credit Rating

Albert David Credit Rating

CARE EDGE Ratings reaffirmed ratings for Albert David's bank facilities. Total rated facilities amount to ₹62.50 crore.

Value
₹62.50 Cr
15:09 IST BSE
Management Change

Albert David Management Change

Albert David Limited announced the resignation of Mr. Chandra Bhushan Thakur as Head-Operations (Ghaziabad). The departure was effective from May 29, 2026, due to personal reasons.

16:09 IST BSE
Other Announcement

Albert David Other Announcement

Albert David Limited submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report indicates no material non-compliances or regulatory penalties.

17:56 IST NSE
Financial Results

Albert David Financial Results

Albert David Limited reported audited FY2026 results and recommended a ₹2.85 Crore final dividend. The Board also appointed Mr. Amit Mahla as CEO.

Value
₹0.29 Cr
17:56 IST NSE
Management Change

Albert David Management Change

Albert David Limited appointed Amit Mahla as Chief Executive Officer effective May 12, 2026. He brings 28 years of pharmaceutical leadership experience from JB Pharma and Cipla.

15:59 IST NSE
Financial Results

Albert David Financial Results

Albert David Limited reported annual Total Income of ₹341.05 Crore for FY2025-26. The board approved results on May 12, 2026, with an unmodified audit opinion.

Value
₹341.1 Cr
00:42 IST BSE
Financial Results

Albert David Q4 FY26 Results: Net Loss of ₹21.4 Cr, Loss Widens

Albert David Ltd reported revenue from operations of ₹85.9 Cr (+14.7% YoY) and a net loss of ₹21.4 Cr for Q4 FY26.

Key figure
Net loss ₹21.4 Cr
18:29 IST BSE
Financial Results

Albert David Financial Results

Albert David Ltd reported audited financial results and recommended a ₹5.00 per share final dividend. Mr. Amit Mahla was appointed as the new CEO.

Value
₹5.00 Cr
15:26 IST BSE
Board Meeting Date

Albert David Board Meeting Date

Albert David Ltd has scheduled a Board Meeting on May 12, 2026, to consider and approve audited financial results and recommend a final dividend for FY 2025-26. The trading window for designated persons is currently closed until 48 hours after the results declaration.